UroGen Pharma (UR8.STU) Q3 2026 Earnings

6AugConfirmed
Q2 2026
Next
-0.41
-0.36
-0.31
-0.26

Details

Expected EPS
-0.26213497324999996
Actual EPS
N/A
Surprise EPS
0.26
Surprise Percent
+100%

Description

UroGen Pharma (UR8.STU) will report earnings of for Q3 2026 on August 06, 2026.

0 Comments

Share your thoughts